共 50 条
- [5] The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs Arthritis Research & Therapy, 19
- [9] Evaluation of the Rheumatoid Arthritis Observation of Biologic Therapy risk score in Japanese patients with rheumatoid arthritis starting first biologic disease-modifying antirheumatic drugs: A validation study using the Institute of Rheumatology, Rheumatoid Arthritis cohort data MODERN RHEUMATOLOGY, 2023, 34 (04) : 693 - 699